What is ARKG's market cap?

$2.29B, based on the Sep 28 close of $53.35.

Cboe BZX · ARKG

ARK Genomic Revolution ETF (ARKG)

$53.35−0.02%

Close Sep 28, 2026 · split-adjusted

Sep 28, 2026$53.35▲ 95.64% in range

Sep 29, 2025Low $24.82 · High $53.53Sep 28, 2026

What changed · written from our data

As of Sep 28, 2026

ARK Genomic Revolution ETF closed at $53.35 on Sep 28, down 0.02%, 0.3% below its 52-week closing high. Volume of 2.5M shares was 0.63× its 20-day average (below normal).

Split-adjusted performance: +7.0% over one month, +113.3% over six months, +100.0% over one year.

Short interest was 25.0M shares at the Sep 15 settlement, down 8.1% from the prior report (8.3 days to cover).

Market cap$2.29B42.9M shares

Revenue · quarter——

Diluted EPS——

P/E · TTM—

Net margin—

Dividend yieldNone$0.3824 last paid

52-week range24.82 – 53.53−0.3% from high

Volume2.5M0.63× 20-day avg

Volatility · 60d43.7%Annualised

Short % of float—8.3 days to cover

Net cash—

Next earnings—Not scheduled

Split-adjusted performance

1W +3.0%1M +7.0%3M +25.9%6M +113.3%YTD +84.2%1Y +100.0%3Y +89.0%5Y −33.6%

Earnings reactions

History →

No reported quarters with price history yet.

Rank within industry

Not enough peers to rank

6-month momentum—

Revenue growth—

Net margin—

Value (low P/E)—

Size—

Short interest

Details →

Shares short25.0M−8.1% vs prior

Days to cover8.3Settled Sep 15

% of float—

Short vol. 10d51.7%of daily volume

News about ARK Genomic Revolution ETF

All news →

No recent articles focused on ARK Genomic Revolution ETF. 3 articles mention it in passing.

Quick answers

What is ARKG's market cap?: $2.29B, based on the Sep 28 close of $53.35.

Sources: Massive / Polygon daily aggregates (split-adjusted) · SEC filings via Massive · FINRA settlements via Massive · Financial Modeling Prep. Figures are dated where shown; research is informational, not investment advice. Methodology